Development of a Chimeric Anti-Cd40 Monoclonal Antibody That Synergizes With LEA29Y to Prolong Islet Allograft Survival

Journal of Immunology - United States
doi 10.4049/jimmunol.174.1.542
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

T Cell Immunity to Lymphoma Following Treatment With Anti-Cd40 Monoclonal Antibody

Journal of Immunology
AllergyImmunology
2002English

Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40

Cancer Research
Cancer ResearchOncology
2005English

Intact Active Bone Transplantation Synergizes With Anti-Cd40 Ligand Therapy to Induce B Cell Tolerance

Journal of Immunology
AllergyImmunology
2002English

Complement Alone Drives Efficacy of a Chimeric Antigonococcal Monoclonal Antibody

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2019English

Anti-Muc1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in Vivo Ovarian Cancer Model

PLoS ONE
Multidisciplinary
2011English

Anti-Antibody Activity of a Monoclonal Macroglobulin

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1971English

Phase I Study of Chimeric Anti-Cd20 Monoclonal Antibody in Chinese Patients With CD20-positive Non-Hodgkin’s Lymphoma

Chinese Journal of Cancer Research
Cancer ResearchOncology
2016English

Multispecificity of a Recombinant Anti-Ras Monoclonal Antibody

Journal of Molecular Recognition
Structural BiologyMolecular Biology
2017English

CD40/anti-CD40 Antibody Complexes Which Illustrate Agonist and Antagonist Structural Switches

BMC Molecular and Cell Biology
Cell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy